MOS
ALXN

MGO One Seven’s Alexion Pharmaceuticals ALXN Stock Holding History

MGO One Seven’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,055
Closed -$1.11M – 652
2021
Q2 		$1.11M Sell
6,055
-579
-9% -$99.4K 0.16% 167
2021
Q1 		$1.01M Sell
6,634
-1,898
-22% -$294K 0.17% 147
2020
Q4 		$1.33M Sell
8,532
-74
-0.9% -$9.51K 0.27% 90
2020
Q3 		$985K Sell
8,606
-316
-4% -$34.1K 0.23% 105
2020
Q2 		$1M Buy
8,922
+122
+1% +$13K 0.26% 103
2020
Q1 		$790K Buy
+8,800
New +$864K 0.27% 96
2019
Q3 		– Sell
-1,586
Closed -$207K – 469
2019
Q2 		$207K Buy
1,586
+86
+6% +$11.1K 0.07% 365
2019
Q1 		$202K Buy
1,500
+687
+85% +$85.4K 0.07% 379
2018
Q4 		$79K Buy
+813
New +$96.1K 0.03% 530
2018
Q1 		$61K Buy
544
+7
+1% +$837 0.03% 559
2017
Q4 		$64K Buy
+537
New +$65.4K 0.03% 545

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return